Skip to main content
TipRanks
Go Ultimate75% OFF

Immuneering (IMRX) Q4 2023 Earnings Report

695 Followers

IMRX Q4 2023 EPS Results

Actual EPS
-$0.52
Consensus EPS
-$0.46
Beat/Miss
Missed by -$0.06
One Year Ago EPS
-$0.50

IMRX Q4 2023 Revenue Results

Actual Revenue
$0
Expected Revenue
$0
Beat/Miss
Met expectations
YoY Revenue Growth
-100.00%

Earnings Announcement Details

Quarter
Q4 2023
Date
03/01/2024
Time
Before Open
Conference Call
Friday, March 1, 2024
IMRX Upcoming Earnings

Immuneering's next earnings date is estimated for March 11, 2027, based on past reporting schedules.

Q4 2023 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

IMRX Earnings History

IMRX earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 11, 20272026 (Q4)-0.41--0.18――
Oct 29, 20262026 (Q3)-0.30-0.37-0.382.63% (+0.01)
Aug 05, 20262026 (Q2)-0.27-0.27-0.432.50% (+0.13)
May 15, 20262026 (Q1)-0.25-0.21-0.4250.00% (+0.21)
Mar 06, 20262025 (Q4)-0.31-0.18-0.5868.97% (+0.40)
Nov 12, 20252025 (Q3)-0.39-0.38-0.4922.45% (+0.11)
Aug 13, 20252025 (Q2)-0.40-0.40-0.4714.89% (+0.07)
May 05, 20252025 (Q1)-0.53-0.42-0.4914.29% (+0.07)
Mar 20, 20252024 (Q4)-0.42-0.58-0.52-11.54% (-0.06)
Nov 13, 20242024 (Q3)-0.55-0.49-0.43-13.95% (-0.06)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed